Dr. Anil Aribandi
Verified Senior ConsultantHematologyCitizens Specialty Hospital - American Oncology Institute

Dr. Anil Aribandi

Qualifications:MBBS, MD, MRCP (UK), CCT
Experience
26+ Years
Surgeries
1000+ Done
Primary Hospital
Citizens Specialty Hospital - American Oncology Institute
Second Opinion
24–48h

Professional Background & Biography

Dr. Anil Aribandi is one of the leading physicians in Haemato Oncology and is associated with American Oncology Institute, Hyderabad as Sr. Consultant Haematology, Haemato-Oncology and Bone Marrow Transplantation (BMT). He earned his medical degree from Kakatiya Medical College, Hyderabad, Telangana, India. He then completed his Masters in General Medicine from Osmania Medical College, Hyderabad, Telangana, India. He pursued his higher medical training program in clinical Hematology in the United Kingdom leading to FRCPath (Hematology) degree.

Dr. Anil has been trained in Hematology in the UK and has been a consultant in NHS, UK. As an experienced Haemato-oncologist, he has expertise in blood and blood related disorders including leukaemia, myelodysplastic syndromes, lymphomas, multiple myeloma, amyloidosis, bone marrow/stem cell transplant, bleeding and clotting disorders, thalassemias and sickle cell anaemia, aplastic anaemia, complicated anemias amongst Others.

Dr. Anil has been awarded Certificate of completion of specialist training (CCT) and then enlisted in the Specialist Register as a fully qualified Haemato-oncologist with licence to practise as an independent Consultant by General Medical Council (GMC), United Kingdom.

Clinical Focus & Areas of Expertise

Haemato-oncology
Stem Cell Transplantation
Clinical Hematology
Hemostasis and thrombosis

Key Procedures & Surgical Treatments

Leukemia
Lymphoma
Myeloma
Amyloidosis
Autologous
Allogeneic
Thalassemia
Sickle cell anemia
Iron deficiency
Myelodysplastic syndromes

Positions & Hospital Appointments

Senior Consultant Haemato-Oncologist and Bone Marrow Transplant Specialist at the Citizens Specialty Hospital, Hyderabad

Professional Memberships & Affiliations

European Society of Blood and Marrow Transplantation (EBMT)
British Society of Hematology
European Hematology Association
International Society on Thrombosis & Hemostasis
Royal College of Pathologist
Royal College of Physicians & Surgeons (Glasgow)
Indian Society of Hematology & Blood transfusion
Indian Medical Association

Select Clinical Research & Publications

Complex Bleeding Management-Multidisciplinary Approach. Anil Aribandi, CS Ranjith, K Ashok, Rajesh Mallik Gottipati. Res Pract Thromb Haemost, 2022
Hematological complications of Covid Immunization-Case series. Anil Aribandi, CS Ranjith Kumar, K Ashok Kumar, HemaSphere, 2022.
Generic Elthrombopag with standard Immunosuppressive therapy in Severe Aplastic Anemia. CS Ranjith Kumar, Anil Aribandi, K Ashok kumar. HemaSphere, 2022.
A case of double positive myeloproliferative neoplasm: A diagnostic and therapeutic challenge Anil Aribandi, Anurag Gupta, Suresh K Subramanian Manu Goyal. Indian J Pathol Microbiol Oct-Dec 2021;64(4):820-823.
Refractory Thrombotic Thrombocytopenic Purpura - A Case Report A. Aribandi, C. Ranjith, S. Sushma, T. Surapaneni Res Pract Thromb Hemost. 2021.
Successful Pregnancy in a Patient with Factor XIII Deficiency and Recurrent Miscarriages [abstract]. Surapaneni T, Vadlamani H, Sukayogula M, Ranjith C, Aribandi A. Res Pract Thromb Haemost. 2021; 5 (Suppl 2)
Varied Presentations of TTP. Aribandi A, Ranjith CS. [abstract]. Res Pract Thromb Haemost. 2020; 4 (Suppl 1)
Tuberculosis reactivation following ruxolitinib therapy for myelofibrosis Anil Aribandi, Ranjit Kumar.CS, Rajesh M. Gottipati HemaSphere, 2021;5:(S2)
Profile of Hemophagocytic Lymphohistiocytosis (HLH) Prospective observational study Sirisharani Siddaiahgari, Archana Rauthan, Ranjith CS, JoydeepChakrabartty, Anil Aribandi HemaSphere, 2021;5:(S2)
Neutrophilic leukoaggregates--A rare hematological phenomenon. Sampath Kumar KJ, Lal S, Kalpati K, Lingutla AK, Aribandi A, Sharma A Indian J Pathol Microbiol. 2021 Jan-Mar;64(1):223-224
Direct Case Review

Consult Dr. Anil Aribandi

Send your reports for a free physician evaluation, treatment plan, and hospital package roadmap.

Confidential review under HIPAA protocols
Specialist response within 24–48 hours